Modal Content

AbbVie Partnering Day: Kidney Disease

Chronic kidney disease (CKD), the progressive loss of kidney function, affects 50 million people in the U.S. and Europe alone. CKD is on the rise, driven by higher rates of diabetes, obesity, and hypertension. AbbVie’s renal care pipeline includes potential therapies for CKD and for acute kidney injury, a complication of major surgery that affects 1.2 million people annually. Partnering Day specific areas of interest:

  • Chronic Kidney Disease
  • Acute Kidney Injury
  • Diabetic Nephropathy